Inactivated dengue virus vaccine with aluminium-free adjuvant

摘要

H:/fmt/Interwoven/NRPortbl/DCC/FMT/1071989 L.docx-29/08/2016 The present disclosure concerns compositions that elicit an immune response against dengue virus. Immunogenic compositions comprising at least one inactivated dengue virus antigen and an aluminium-free adjuvant, and methods for their use, e.g., in the formulation of medicaments, for prevention of treatment of disease caused by Dengue virus are described.